Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 15, 2018
VALNEVA Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth
Lyon (France), February 15, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing and commercializing innovative, ...
February 15, 2018
Addex Launches CHF40 million Capital Increase with Commitment from Specialist US Healthcare Investors
Geneva, Switzerland, 15 February 2018 - Addex Therapeutics (ADXN.SW), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Board of ...
February 15, 2018
Zealand Pharma's dasiglucagon Phase 2a results at the 11th International Conference on ATTD
Copenhagen, February 15, 2018 - Dr. Steven J. Russell, Massachusetts General Hospital, Boston, U.S., principal investigator for Zealand Pharma`s ("Zealand") Phase 2a trial of dasiglucagon in ...
February 15, 2018
CytoSorbents Expands Its Partnership with Biocon to Launch CytoSorb® in Malaysia
MONMOUTH JUNCTION, N.J., Feb. 15, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and cardiac ...
February 15, 2018
Data from BioTime's OpRegen® and Vision Restoration Programs to Be Presented at ARVO 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced that two abstracts have ...
February 15, 2018
Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has received approval from the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) and ...
February 15, 2018
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
BOSTON, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
February 15, 2018
Prometic granted orphan drug designation by FDA for Inter-Alpha-Inhibitor-Proteins for treatment of necrotizing enterocolitis (NEC)
LAVAL, QC, Feb. 15, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") announced today that an orphan drug designation status has been granted to ...
February 14, 2018
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017
HOUSTON and VANCOUVER, Feb. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing ...
February 14, 2018
Sensorion Presents New SENS-401 Data at ARO 2018 MidWinter Meeting
MONTPELLIER, France, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Sensorion (ALSEN.PA), a biotech company specializing in the treatment of inner ear diseases, today announces new data ...
February 14, 2018
Galmed Announces ARRIVE Study Data
TEL AVIV, Israel, Feb. 14, 2018 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
February 14, 2018
DURECT Announces Resubmission of REMOXY® ER New Drug Application by its licensee, Pain Therapeutics
CUPERTINO, Calif., Feb. 14, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that its licensee, Pain Therapeutics (PTIE), reported yesterday that it has resubmitted the ...
February 14, 2018
Aimmune Therapeutics Expands Scientific Advisory Board With Appointments of George du Toit, M.B., B.Ch., and Wayne Shreffler, M.D., Ph.D.
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the expansion of its Scientific Advisory Board ...
February 14, 2018
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer
RA’ANANA, Israel and NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
February 13, 2018
Heron Therapeutics to Present at the 7th Annual Leerink Partners Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient ...
February 13, 2018
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial
IRVING, Texas, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced results from the long-term ...
February 13, 2018
Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development
SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that Dr. Christine Esau, Senior Director ...
February 13, 2018
Moberg Pharma AB Year-end Report 2017
STRONG GROWTH FOR KERASAL NAIL INCREASES EBITDA STOCKHOLM, Feb. 13, 2018 /PRNewswire/ -- PERIOD (FULL YEAR 2017)* Net revenue SEK 439.0 million (334.3) EBITDA SEK ...
February 13, 2018
Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28
REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
February 13, 2018
BioLife Solutions Executes OEM Agreement with MilliporeSigma
BOTHELL, Wash., Feb. 13, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media ("BioLife" or ...
Page 65 of 117